ScoreWhy is CRISPR Therapeutics AG ?
1
Poor Management Efficiency with a low ROE of 3.15%
- The company has been able to generate a Return on Equity (avg) of 3.15% signifying low profitability per unit of shareholders funds
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -5.65%, its profits have fallen by -35.6%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -5.65% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CRISPR Therapeutics AG for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
CRISPR Therapeutics AG
-5.65%
-0.21
58.78%
S&P 500
22.61%
1.71
13.21%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
30.54%
EBIT Growth (5y)
-16.89%
EBIT to Interest (avg)
-271.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.07
Tax Ratio
1.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
89.30%
ROCE (avg)
229.94%
ROE (avg)
3.15%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.29
EV to EBIT
-4.28
EV to EBITDA
-4.44
EV to Capital Employed
-56.53
EV to Sales
693.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-25.84%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
NET SALES(HY)
Higher at USD 11.64 MM
RAW MATERIAL COST(Y)
Fallen by -93.82% (YoY
CASH AND EQV(HY)
Highest at USD 4,806.91 MM
OPERATING PROFIT(Q)
Highest at USD -110.5 MM
PRE-TAX PROFIT(Q)
Highest at USD -93.82 MM
NET PROFIT(Q)
Highest at USD -94.78 MM
EPS(Q)
Highest at USD -0.94
-7What is not working for the Company
NET SALES(9M)
At USD 12.5 MM has Grown at -66.61%
OPERATING CASH FLOW(Y)
Lowest at USD -369.58 MM
Here's what is working for CRISPR Therapeutics AG
Net Sales
At USD 11.64 MM has Grown at 562.44%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Sales
Higher at USD 11.64 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Operating Profit
Highest at USD -110.5 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD -93.82 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -94.78 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.94
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 4,806.91 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -93.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for CRISPR Therapeutics AG
Operating Cash Flow
Lowest at USD -369.58 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
